A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma
研究单位：[1]Qilu Pharmaceutical Co., Ltd.[2]Peking University Third Hospital Beijing, Beijing, China, 100000[3]Shengjing Hospital affiliated to China Medical University Beijing, Beijing, China, 100000[4]Foshan First People's Hospital Foshan, Guangdong, China, 528000[5]Guangzhou First People's Hospital Guangzhou, Guangdong, China, 510000[6]The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China, 510000[7]The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510080[8]Guizhou Provincial People's Hospital Guiyang, Guizhou, China, 550000[9]The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China, 050000河北医科大学第四医院[10]The Third Hospital of Hebei Medical University Shijiazhuang, Hebei, China, 050000[11]Henan Tumor Hospital Zhengzhou, Henan, China, 450000[12]The First Affiliated Hospital of Nanhua University Hengyang, Hunan, China, 421200[13]Shandong University Qilu Hospital Jinan, Shandong, China, 250000[14]Affiliated Hospital of Qingdao University Qingdao, Shandong, China, 266000[15]Weifang People's Hospital Weifang, Shandong, China, 261000[16]Weihai Central Hospital Weihai, Shandong, China, 264200[17]Shanxi Cancer Hospital Taiyuan, Shanxi, China, 030000[18]The Second Hospital of Shanxi Medical University Taiyuan, Shanxi, China[19]Second Affiliated Hospital of Xi 'an Jiaotong University Xi'an, Shanxi, China, 710000[20]Sichuan Provincial People's Hospital Chengdu, Sichuan, China, 610000[21]Tianjin Cancer Hospital Tianjin, Tianjin, China, 300000[22]Yunnan Cancer Hospital Kunming, Yunnan, China, 650000[23]The First Affiliated Hospital of Zhejiang University Medical College (Hematology) Hangzhou, Zhejiang, China, 310000[24]Beijing Chaoyang Hospital, Capital Medical University Beijing, Beijing, China, 100000
